CSU.TO 67.76NFLX 0.62LLY 6.15EVR -7.36MSFT -11.38DAL -0.09JPM 1.48
Daily Stock Opinions and Ratings
Stockchase Opinions

Malvin SpoonerIsotechnnika IncISA.TOTOP PICKNov 13, 2001

Good product and is in phase 2. Volatile.
Malvin SpoonerMalvin Spooner
Unknown
Unlock Rating
$4.48

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Isotechnnika Inc(ISA.TO)

Nov 18, 2008
Nothing fundamentally horrible about this company but it does have a small market cap, which is an out-of-favour sector. Small cap biotech sector is not a place to be.
Photo of Duncan StewartDuncan Stewart
No
Unlock Rating
$0.12

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Isotechnnika Inc(ISA.TO)

Apr 14, 2005
Drug development. Burning up cash hand over fist. In sloppy markets you have to watch out. There's no earnings or fundamental support. Very early stages in drug development and will have to raise money, so will dilute shareholders.
Photo of Chris FernycChris Fernyc
No
Unlock Rating
$2.65

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Isotechnnika Inc(ISA.TO)

Jan 07, 2005
Their particular area of expertise is getting involved with drugs that are involved with transplants that reduce rejection. Outlook for the company is quite interesting. In phase 2 and 3 trials so they still have a ways to go. Speculative.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$2.18

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Jan 26, 2004
Has a better product than cyclosporine. This should create a great marketplace for them. With more results coming out in 2004, you should see the stock move-up quite nicely.
Photo of Mike WeirMike Weir
Owned
Unlock Rating
$2.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Dec 22, 2003
Thinks the stock should move up from this level. Have a good opportunity to bring their product to market. Should rally by the middle of 2004.
Photo of Mike WeirMike Weir
Owned
Unlock Rating
$2.67

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Sep 09, 2003
Solid growth company. Well along in clinical trials. Well run and the upside is pretty good. Some good partnerships. Good product. If you want a Cdn biotech, this is a good one.
Photo of Peter HodsonPeter HodsonUnlock Rating
$3.63

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Jul 04, 2003
An interesting little company. Good cash position. Strong management.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$3.48

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Mar 05, 2003
Has been able to meet ,ilestones.
Photo of Mike WeirMike WeirUnlock Rating
$3.10

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Jul 10, 2002
Strong joint venture. Should move up as the clinical trials go through.
Photo of Robert FloydRobert FloydUnlock Rating
$4.05

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Jan 16, 2002
Prefers over Biomira.
Photo of Ray SteeleRay SteeleUnlock Rating
$4.05

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

Nov 09, 2001
Well funded in their product line.
Photo of Robert FloydRobert FloydUnlock Rating
$4.69

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Isotechnnika Inc(ISA.TO)

May 04, 2001
Expects it to get some partners.
Photo of Malvin SpoonerMalvin SpoonerUnlock Rating
$3.70

Stock price when the opinion was issued

biotechnologypharmaceutical
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

JNJ 4.6$232.77
FDFX 0$
RDDT -10.46$173.45
MCD 7.12$279.84
AZN 4.15$185.95

Today's Top Picks

CSU.TO 67.76$2969.32
NFLX 0.62$82.18
LLY 6.15$1131.42
EVR -7.36$339.43
MSFT -11.38$416.67

Popular Articles

Latest Sell Signals

OBDC -0.28$11.02
BWA -4.4$72.63
RAL 0$
STWD -0.04$17.05
NKE -0.64$42.98

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Brian Madden

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica